Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2020 15:10 ET | Source: The Rosen Law Firm PA

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm – TEVA

NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA)...
August 13, 2020 10:34 ET | Source: PMI

Global Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Covina, CA, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The report "Global Neurodegenerative Disorder Therapeutics Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis,...
July 23, 2019 12:04 ET | Source: Barbuto & Johansson

Teva May have a Problem Resulting from Opioid Epidemic: Barbuto & Johansson, P.A. Updates Investors of Class Action Lawsuit Against Teva Pharmaceutical

WELLINGTON, Fla., July 23, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
July 18, 2019 11:04 ET | Source: Barbuto & Johansson

Barbuto & Johansson, P.A. reminds TEVA, EQT, FRED and RBGLY Shareholders of Class Action Deadlines

WELLINGTON, Fla., July 18, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
July 01, 2019 03:00 ET | Source: Barbuto & Johansson

Barbuto & Johansson, P.A. Informs Investors of the Pending Class Action Lawsuit Against Teva Pharmaceutical and Encourages Investors to Contact the Firm

WELLINGTON, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
January 08, 2019 12:56 ET | Source: B. Braun Medical Inc.--US

B. Braun’s OnGuard® CSTD Qualifies as an Effective Barrier for Vapor Release Based on the NIOSH Draft Universal Protocol

BETHLEHEM, Pa., Jan. 08, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today that OnGuard® Closed System Transfer Device (CSTD) demonstrated effective barrier performance under the...
September 19, 2018 07:00 ET | Source: Global Market Insights, Inc

U.S. Intrauterine Devices Market worth over $2.0 bn by 2024: Global Market Insights, Inc.

Sellbyville, Delaware, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The U.S. Intrauterine Device Market will surpass USD 2.0 billion by 2024; according to a new research study published by Global Market...
December 27, 2016 09:00 ET | Source: The Rosen Law Firm PA

TEVA REMINDER: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important January 5 Deadline in Class Action Filed by Firm- TEVA

NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares (“ADSs”) of Teva Pharmaceutical Industries Limited...
December 12, 2016 18:23 ET | Source: The Rosen Law Firm PA

Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA

NEW YORK, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the American Depositary...
June 27, 2011 13:04 ET | Source: InvestorIdeas.com

Biotech/Pharma Stocks Battle for the Sexual Health Market: BioSante Pharmaceuticals, (NASDAQ: BPAX), Pfizer, Teva Pharmaceutical, Watson

POINT ROBERTS, WA--(Marketwire - Jun 27, 2011) - Investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, features a sector snapshot of...